IL-2 gene transduction in malignant cells: applications in cancer containment.
Roth
C
C
Unité de Biologie Moléculaire du Gène, U.277 INSERM, Institut Pasteur, Paris, France.
Mir
L
L
Cressent
M
M
Quintin-Colonna
F
F
Ley
V
V
Fradelizi
D
D
Kourilsky
P
P
D000818:Animals; D004357:Drug Synergism; D015316:Genetic Therapy; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D007378:Interleukins / Q000008:administration & dosage / Q000627:therapeutic use; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D007155:Immunologic Factors; D007376:Interleukin-2; D007378:Interleukins